Drug Metabolism Letters
Volume 14, 3 Issues, 2020
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
  |
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research
Contents
Drug Metabolism Letters, Volume 10 - Number 1
A Novel Plated Hepatocyte Relay Assay (PHRA) for In Vitro Evaluation of Hepatic Metabolic Clearance of Slowly Metabolized Compounds
, 10(1): 3 - 15Chi-Chi Peng, Utkarsh Doshi, Chandra Prakash and Albert P. Li
DOI: 10.2174/1872312809666150818111500
A Novel Plated Hepatocyte Relay Assay (PHRA) for In Vitro Evaluation of Hepatic Metabolic Clearance of Slowly Metabolized Compounds
Inactivation of CYP3A4 by Benzbromarone in Human Liver Microsomes
, 10(1): 16 - 21Yasuhiro Masubuchi and Shinji Kondo
DOI: 10.2174/1872312810666151223103208
Inactivation of CYP3A4 by Benzbromarone in Human Liver Microsomes
Metabolism, Excretion and Pharmacokinetics of MLN3897, a CCR1 Antagonist, in Humans
, 10(1): 22 - 37Sandeepraj Pusalkar, Mihaela Plesescu, Mark Milton, Suresh K. Balani, Swapan Chowdhury and Shimoga Prakash
DOI: 10.2174/1872312809666150602152423
Metabolism, Excretion and Pharmacokinetics of MLN3897, a CCR1 Antagonist, in Humans
Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions
, 10(1): 38 - 48Florence Namour, Julie Desrivot, Annegret Van der Aa, Pille Harrison, Chantal Tasset and Gerben van't Klooster
DOI: 10.2174/1872312810666151223103353
Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions
Induction of Haemolysis and DNA Fragmentation in a Normal and Malarial-Infected Blood by Commonly - used Antimalarial Drugs in the North-Western Region of Nigeria
, 10(1): 49 - 55Aliyu Muhammad, Mohammed Auwal Ibrahim, Ochuko Lucky Erukainure, Nathan Habila, Aimola Asegame Idowu, Uche Samuel Ndidi, Ibrahim Malami, Halliru Zailani, Zeenat Bello Kudan and Bilal Abdullahi Muhammad
DOI: 10.2174/187231281001160212150630
Induction of Haemolysis and DNA Fragmentation in a Normal and Malarial-Infected Blood by Commonly - used Antimalarial Drugs in the North-Western Region of Nigeria
Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes
, 10(1): 56 - 64Hannu Raunio, Risto O. Juvonen, Antti Poso, Maija Lahtela-Kakkonen and Minna Rahnasto-Rilla
DOI: 10.2174/1872312810666151204002456
Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes
Impact of Cytochrome P450 2C19*2 and *3 on Clopidogrel Loading Dose in Saudi Patients with Acute Coronary Syndrome
, 10(1): 65 - 70Hassan Khalaf, Ahmad AbdulRahman Al Meman and Seemab Rasool
DOI: 10.2174/1872312810666151117122841
Impact of Cytochrome P450 2C19*2 and *3 on Clopidogrel Loading Dose in Saudi Patients with Acute Coronary Syndrome
Editor-in-Chief
Zhiyang Zhao
Alliance Pharma
Malvern, PA
(USA)
Biography
View Full Editorial Board
Alliance Pharma
Malvern, PA
Biography
Biography of Zhiyang Zhao
Zhiyang Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia, USA. Dr. Zhao’s biopharmaceutical/pharmaceutical work experience encompasses over 25 years of research in metabolic and pharmacokinetic properties of compounds for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen. Currently, Dr. Zhao serve as Chief Scientific Officer (CSO) at Alliance Pharma, Inc. and appointed as an adjunct professor at the School of Pharmacy, the University of North Carolina at Chapel Hill. Dr. Zhao has published over 50 peer reviewed original research papers and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Drug Metabolism Letters was launched in 2007. Dr. Zhiyang Zhao serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.01
Advertisement
Webmaster Contact: info@benthamscience.net